HHLA3 Polyclonal Antibody, AbBy Fluor™ 594 Conjugated
Product Specifications
Background
HHLA3
Synonyms
HERV H LTR associating protein 3; HERV-H LTR-associating 3; Human endogenous retrovirus H long terminal repeat associating protein 3; Human endogenous retrovirus-H long terminal repeat-associating 3; HHLA3_HUMAN.
Cellular Locus
Nucleus
Host
Rabbit
Immunogen
41-114/114
Target
HHLA3
Clonality
Polyclonal
Isotype
IgG
Conjugation
AbBy Fluor™ 594
Source
KLH conjugated synthetic peptide derived from human HHLA3
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
590nm/617nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Predicted Cross Reactivity
Human
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1177217-01 0.5 mg (E-Coli)
Recombinant Newcastle disease virus Fusion glycoprotein F0 (F), partial
Ask
View Details 
MBS1177217-02 0.05 mg (Baculovirus)
Recombinant Newcastle disease virus Fusion glycoprotein F0 (F), partial
Ask
View Details MBS1177217-03 0.5 mg (Yeast)
Recombinant Newcastle disease virus Fusion glycoprotein F0 (F), partial
Ask
View Details MBS1177217-04 0.05 mg (Mammalian-Cell)
Recombinant Newcastle disease virus Fusion glycoprotein F0 (F), partial
Ask
View Details 
MBS1177217-05 1 mg (E-Coli)
Recombinant Newcastle disease virus Fusion glycoprotein F0 (F), partial
Ask
View Details